Yield10 Bioscience, Inc. (YTEN)
$2.84
Rating:
Recommendation:
Buy
| Symbol | YTEN |
|---|---|
| Price | $2.84 |
| Beta | 1.760 |
| Volume Avg. | 0.28M |
| Market Cap | 14.410M |
| Shares () | - |
| 52 Week Range | 1.63-6.12 |
| 1y Target Est | - |
| DCF Unlevered | YTEN DCF -> | |
|---|---|---|
| DCF Levered | YTEN LDCF -> | |
| ROE | -154.59% | Strong Sell |
| ROA | -167.79% | Strong Sell |
| Operating Margin | - | |
| Debt / Equity | 83.75% | Buy |
| P/E | -1.08 | Sell |
| P/B | 3.19 | Strong Buy |
Latest YTEN news
About
Download (Excel)Yield10 Bioscience, Inc., an agricultural bioscience company, engages in developing technologies to enable step-change increases in crop yield in the United States and Canada. The company, through its Trait Factory, a trait gene discovery platform develops enhanced oilseed Camelina sativa for the production of proprietary seed products; and discovers high value genetic traits for the agriculture and food industries. Yield10 Bioscience, Inc. has license agreements with GDM Seeds; J. R. Simplot; Forage Genetics International, LLC; and Bayer AG. The company was formerly known as Metabolix, Inc. and changed its name to Yield10 Bioscience, Inc. in January 2017. Yield10 Bioscience, Inc. was incorporate in 1992 and is headquartered in Woburn, Massachusetts.